Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19 - NPR

1. Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19  NPR
2. Johnson & Johnson's Covid-19 vaccine, how it works and why it matters  CNN
3. Johnson & Johnson’s Vaccine Offers Strong Protection but Fuels Concern About Variants  The New York Times
4. Johnson & Johnson's Covid-19 Vaccine Is Good, Despite Lower Efficacy  Bloomberg
5. Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says  CNN
6. View Full Coverage on Google News

from Top stories - Google News https://ift.tt/3pqS37z